The global body armor plates market size was valued at USD 1.6 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2020 to 2027. The body armor plates function as a shield and provide a protection layer in protection suits. They are typically made from a combination of ceramics and bullet-resistant fabrics or materials.
The growing number of soldiers' casualties and inflicting fatal injuries due to the rising terrorism and hostile activities around the world propels the need for ballistic protection suits for safeguarding armed forces. The rise in asymmetric warfare activities and cross-border tension worldwide pushes several governments to go for soldier's modernization program to increase soldier's survivability. The program includes the acquisition of modern protection equipment and shields for the armed forces. The modernization program has also created several opportunities for industry participants, leading to alliances with military agencies in a contractual environment. For instance, in July 2019, KDH Defense Systems, a U.S.-based body armor manufacturer, received two separate delivery orders worth USD 40.0 million from the U.S. Armed Forces.
Request a Free Sample @: https://www.grandviewresearch.com/industry-analysis/body-armor-plates-market/request/rs1
The technological advancements and the increasing availability of lightweight body armor globally are expected to drive the market for body armor plates over the forecast period. For instance, Kevlar vests' liquid armor is an enhanced technology innovated at the U.S. Army Research Laboratory to safeguard soldiers' lives. It is flexible and light, allowing soldiers to move more and with ease while running or aiming their weapons. It turns into a rigid material once the bullet knocks the armor and, thus, protects soldiers from being shot. Further, to ease discomfort and reduce the fatigue that reduces the soldier's tactical effectiveness, enhanced body armor systems are being developed. Sensor Products Inc. is developing a body mapping pressure system called Tactilus that will help designers and engineers build ballistic protection suits capable of optimally distributing the soldiers' load.
Key Player Mentioned:
- Aegis Engineering Ltd
- Armored Republic, LLC
- BAE Systems
- Ballistic Body Armour Pty.
- Ceradyne Inc. (Subsidiary of 3M)
- Craig International Ballistics Pty Ltd
- Hellweg International
- Kejo Limited Company
Product Segment Analysis:
- Level IIA
- Level II
- Level IIIA
- Level III
- Level IV
Application Segment Analysis:
- Defense
- Law Enforcement Protection
- Civilians
Access Press Release @ https://www.grandviewresearch.com/press-release/global-body-armor-plates-market
Level IV body armor plate led the market for body armor plates and accounted for the largest revenue share of over 25.0% in 2019. This segment is anticipated to grow at a noticeable rate over the forecast period. This growth is attributable to the fact that the introduction of the final version of NIJ (National Institute of Justice) Standard 0101.07 is anticipated to improve the test methods and the performance requirements for the ballistic resistance levels. Besides, the new NIJ standard is expected to bring new threat levels for rifle protection levels. The increased vulnerability to the rifle protection levels is expected to contribute to the growth of the level IV armor plate.
The market for body armor plates is highly concentrated and competitive due to leading vendors to offer advanced products, thereby driving internal rivalry. The key players are striving to increase their customer portfolio to gain a competitive advantage in the market. Hence, they are focusing on expansion activities such as collaborations, partnerships, and mergers & acquisitions. For instance, in August 2019, Avon Rubber p.l.c. acquired 3M’s ballistic protection unit and rights to the Ceradyne brand. This acquisition was a strategic initiative to win the U.S. Army’s contract for body protection plates.
KEY aspects covered in the report include:
- The market size and industry growth rate of the global and regional market across various segments
- The region or the sub-segment that is expected to drive the Body Armor Plates market in the forecast period 2021-2028
- Key companies operating in the global Body Armor Plates market and their market share
- The Factors that are estimated to drive the Body Armor Plates Market growth
- Key opportunities in the Body Armor Plates market
- Key technological advancements and market trends that shape the market
The study objectives of this report are:
- To research global status, future forecasts, growth opportunities, key markets and key players.
- To present the market development in us, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and methods.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Proficiency testing forms an essential precondition for operational excellence and accreditation in several industries.
This is one of the major factors driving the growth of the proficiency testing market, globally.
Also, the stringent safety and quality regulations for food and pharmaceutical products and the increasing focus on water testing are the other major factors supporting market growth.The Laboratory Proficiency Testing Market is projected to reach USD 1,103 million by 2024 from USD 800 million in 2019, at a CAGR of 6.6% during the forecast period.Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144227949The cannabis/opioids proficiency testing segment is estimated to grow at the highest CAGR in the laboratory proficiency testing market, by industry, during the forecast periodIn the laboratory proficiency testing market, by industry, the cannabis/opioids proficiency testing segment is estimated to grow at the highest CAGR during the forecast period.
Growth in this segment is primarily driven by the legalization of medical cannabis, growing number of cannabis testing laboratories, rising awareness about the medical use of cannabis, and the increasing availability of analytical testing instruments and software.The proficiency testing market for chromatography is estimated to grow at the highest CAGR in the laboratory proficiency testing market, by technology, during the forecast periodIn the laboratory proficiency testing market, by technology, the chromatography segment is expected to grow at the highest CAGR during the forecast period.
Chromatography is used to carry out complicated separations like amino acid sequencing or pollutant separations, based on differential partitioning between the mobile and stationary phase.
The advantages associated with chromatographic testing, such as the increased safety, reliability, and transparency of the pharmaceutical supply chain by testing the identity, strength, purity, quality, and potency of a drug product, and the growth in the pharmaceutical industry as a whole are the major factors driving the growth of this segment.The Asia Pacific region holds high growth potential in the laboratory proficiency testing marketThe Asia Pacific is considered to be the most attractive regional market for laboratory proficiency testing owing to the large base of manufacturers and research laboratories in the region.
Market Analysis: Global Lambert-Eaton Myasthenic Syndrome Treatment MarketLambert-Eaton myasthenic syndrome treatment market is growing at a steady CAGR in the forecast period of 2019-2026.
Increasing research and development expenses and high demand of novel therapies are some factors fueling the market growth.Global Lambert-Eaton Myasthenic Syndrome Treatment Market By Type (Idiopathic, Paraneoplastic), Treatment Type (Medication, Immune Therapy, Plasmapheresis, Drugs (Potassium Channel Blockers, Cholinesterase Inhibitor, Intravenous Immunoglobulin and Others), Route of Administration (Oral, Parenteral), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retailers and Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026Download Sample Report with related Graphs and Figures@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lambert-eaton-myasthenic-syndrome-treatment-marketMarket Definition: Global Lambert-Eaton Myasthenic Syndrome Treatment MarketLambert-Eaton Myasthenic syndrome is a rare autoimmune disorder that affects the neuromuscular junction.
It is frequently associated with small-cell lung cancer (SCLC).
Increasing research and development expenses and high demand of novel therapies are some factors fueling the market growth.Market DriversPrevalence of small cell lung carcinoma worldwide as Lambert-Eaton Myasthenic syndrome is associated with small cell lung carcinoma is drive the marketIncrease special designation from the regulatory authorities is boosting the market growthHigh demand of novel therapy is accelerating the market growthHuge financial support to the researchers for developing novel intervention is enhancing the market growthMarket RestraintsLimited availability of disease specific treatment options due to low prevalence of Lambert-Eaton Myasthenic syndrome is restraining the market growthHigh cost of chemotherapy and targeted therapy is hindering the market growthLack of trained personnel and stringent safety regulations is hampering the market growthClick here for Detailed Analysis Report@ https://www.databridgemarketresearch.com/reports/global-lambert-eaton-myasthenic-syndrome-treatment-marketCompetitive Analysis:Global Lambert-Eaton myasthenic syndrome treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The report includes market shares of global Lambert-Eaton myasthenic syndrome treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.Key Market Players:Few of the major competitors currently working in the global Lambert-Eaton myasthenic syndrome treatment market are BioMarin, Catalyst Pharma, Jacobus Pharmaceutical Company, Inc, Shenox Pharmaceuticals,LLC, Novartis AG, Zydus Cadila, Alvogen, Apnar pharma, Novitium Pharma, Amneal Pharmaceuticals LLC and othersGet Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-lambert-eaton-myasthenic-syndrome-treatment-marketResearch Methodology: Global Lambert-Eaton Myasthenic Syndrome Treatment MarketData collection and base year analysis is done using data collection modules with large sample sizes.
To know more please request an analyst call or can drop down your enquiry.The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation.
Research Nester released a report titled “Brain Fingerprinting Technology Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global brain fingerprinting technology market in terms of market segmentation by equipment, application, and by region.Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.The global brain fingerprinting technology market is projected to grow with a moderate CAGR during the forecast period, i.e., 2022-2030, on account of the growing technological developments regarding brain fingerprinting technology, and the increasing necessity to counter terrorism and crack complicated criminal cases.
In addition, the use of brain fingerprinting technology helps in significantly reducing the number of unsolved criminal cases and has ample benefits with respect to accuracy and efficiency over conventional crime detection tests, which is anticipated to boost the market growth in the near future.The market is segmented by equipment and application.
Based on equipment, the four-channel electroencephalography amplifier system segment is anticipated to hold the largest share during the forecast period owing to its increasing deployment globally as it measures and amplifies the brainwaves produced when a stimulus helps trigger neurons of the brain.
Furthermore, by application, the national security segment is expected to grow significantly on the back of the growing need to secure national territories as a result of increasing terrorism and territorial dispute-related violence across the world.Request Sample For More Information@ https://www.researchnester.com/sample-request-3271Regionally, the global brain fingerprinting technology market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, Asia Pacific is projected to grow at the highest CAGR throughout the forecast period owing to the growing advancements in the IT sector, and increasing requirement to standardize healthcare and crime detection in the region.
Moreover, the market in North America is assessed to occupy the largest share ascribing to the presence of leading brain fingerprinting technology providers in the region and the rapid adoption of processes to strengthen the security infrastructure.Rising Developments in Brain Fingerprinting Technology to Drive Market GrowthWith the rising population and the constant struggle for control over limited resources, the need for upgrading security has been continuously rising.
Additionally, the increasing requirement for controlling high crime rates and terrorist attacks is also expected to boost the market growth in upcoming years.However, doubts related to the accuracy of the test and the high deployment cost of the technology are some of the factors that are estimated to restrain market growth in the near future.This report also provides the existing competitive scenario of some of the key players of the global brain fingerprinting technology market which includes company profiling of Brainwave Science, Brain Fingerprinting Laboratories Inc, SPARK Neuro, The Nielsen Company (US), LLC, and others.
The global neurovascular devices market size is estimated to reach USD 4.28 billion by 2026, exhibiting a CAGR of 8.3% during the forecast period.
According to the Brain Aneurysm Foundation, an estimated 6 million Americans each year suffer from cerebral aneurysms.
The condition is also responsible for a half-million deaths globally each year.
About 40% of ruptures result in death, and of those who survive, approximately 66% have some permanent brain damage.
These neurovascular devices market trends along with the accessibility of new treatment options will substantively raise the demand for neurovascular devices in the forthcoming years.As per the report, published by Fortune Business Insights, titled “Neurovascular Devices Market Size, Share & Industry Analysis, By Device Type (Stenting Systems, Embolization Devices, Neurothrombectomy Devices and Support Devices), By Application (Cerebral Aneurysms, Ischemic Stroke and Others), By End User (Hospitals, Specialty Clinics and Others) and Regional Forecast, 2019-2026” the market stood at USD2.26 billion in 2018.For More Information : https://www.fortunebusinessinsights.com/industry-reports/neurovascular-devices-interventional-neurology-market-101684Increasing Reimbursement Policies to Enrich Market Potential The government is implementing strict regulations for devices, followed by the implementation of reimbursement policies for the treatment of neurovascular diseases.
Therefore, the increasing availability of reimbursement through public and private health insurance has created a vast space for the expansion of the neurovascular devices market growth.
Ethylene vinyl alcohol (EVOH) films for packaging market in Europe has been witnessing excellent growth as innovation and resource efficiency have remained the backbone of the European packaging industry.
Additionally, leading manufacturers of EVOH films for packaging market in Europe are leveraging growth prospects of the European e-commerce sector for the economic growth of their businesses.
Sensing the opportunities emerging in emerging markets of Latin America, Asia Pacific, and Middle East, leading packaging companies are focusing on consolidating their position in these regions.
Request 100 Page Sample Report from Here - https://www.factmr.com/connectus/sample?flag=S_id=1673Increasing concern about the environmental damages caused due to plastic is influencing consumers to shift towards eco-friendly alternatives for plastic in the packaging industry.
Growing mandates by governments and increasing carbon-consciousness among consumers is influencing manufacturers to alter their production process.
Many players have made a gradual shift from plastic to paper to comply with the evolving demand.
Market Overview:Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with a group of behavioral symptoms that include hyperactivity, inattentiveness and impulsiveness.
The symptoms of ADHD begin in childhood and can continue through adolescence and adulthood.
As per the report published by Market Research Future (MRFR), the global ADHD therapeutics market is registered to grow steadily till the end of 2024.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/1573Market Drivers and Restraints:The symptoms of ADHD such as lack of attention, hyperactivity and impulsivity hamper proper functioning and development of an individual.
Increasing awareness regarding neurodevelopmental disorders and easy availability of diagnostic guidelines over the internet is projected to boost the growth of the global ADHD therapeutics market.Changing lifestyles and value systems along with the factors like genetic inheritance and premature birth are resulting to the rise in prevalence of ADHD among children in the age group of 4-17 years, which in turn is propelling the growth of the global ADHD therapeutics market.
Increasing availability of online platforms for therapists that assure anonymity of the patient is inclining more individuals towards undergoing therapeutic treatment for ADHD, which in turn is fueling the expansion of the global ADHD therapeutics marketHowever, underdiagnosis of ADHD due to the existence of comorbid conditions in children, lack of awareness and low availability of non-stimulant drugs to treat ADHD in various regions are likely to hamper the expansion of the global ADHD therapeutics market during the forecast period.Market Segmentation:The global ADHD therapeutics market has been segmented on the basis of drug type and distribution channel.
Based on drug type, the ADHD therapeutics market is segmented into stimulants and non-stimulants.
